Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Medical Journal of Cairo University [The]. 1996; 64 (Supp. 4): 119-23
in English | IMEMR | ID: emr-42348

ABSTRACT

This study was conducted to assess the value of Doppler flow velocimetry in the diagnosis of dysfunctional uterine bleeding [DUB]. The resistance index [RI] was measured in the uterine and ovarian arteries of 60 patients with [DUB]. The patients were divided according to endometrium histopathology into three 20-patients groups: Proliferative, secretory and endometrial hyperplasia. The results were compared with those of 20 normal controls. The results revealed that the mean uterine artery RI was significantly lower in the three DUB groups compared with the controls, but only with statistical significance in the proliferative and hyperplasia groups. A uterine artery RI <0.58 was associated with endometrial hyperplasia at a sensitivity of 95% and a specificity of 65%. The results endorse the use of Doppler uterine artery TI being an informative and noninvasive parameter for the evaluation of DUB patients


Subject(s)
Humans , Ultrasonography, Doppler/methods
2.
Medical Journal of Cairo University [The]. 1995; 63 (Supp. 1): 63-72
in English | IMEMR | ID: emr-38477

ABSTRACT

This study included 230 females with premenstrual tension syndrome [PMS] compared to 250 females forming the non-PMS group. The results show that educational level, working condition, marital status, parity and contraceptive methods are all involved in the development of PMS. The diagnosed symptoms of premenstrual tension were more common among singles, students, secondary and highly educated females and married women with one or two pregnancies, who use the IUD as a contraceptive method and have breast fed. These factors provide the patient criteria to allow for early intervention to control further complications and to carry out early measures for prevention. The double blind placebo-controlled part evaluated pyridoxine as a treatment for PMS. Pyridoxine did not relieve the symptoms to a statistically significant level, nor did it significantly affect the level of patient's serum prolactin


Subject(s)
Humans , Female , Pyridoxine
SELECTION OF CITATIONS
SEARCH DETAIL